120 day FDA approval cycle. Still probably pushes it out to early next year. This has been obvious for some time now. I don't think the market will respond well to this announcement (neutral at best), but as I've said before, this will most likely only delay the inevitable and create buying opportunities.
Ann: Update on US Clinical Study-RAP.AX, page-17
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)